跳至主要内容
临床试验/NCT00520962
NCT00520962已完成不适用

New Physiopathogenics Mechanisms Susceptible of Pharmacological Developments (Insulin Resistance and Atherosclerosis)

IRCCS San Raffaele1 个研究点 分布在 1 个国家目标入组 1,997 人开始时间: 1997年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,997
试验地点
1

研究概览

简要总结

The study aims to evaluate IFG, IGT or unknown type 2 diabetes mellitus in new classes at high risk to develop alterations of glucose metabolism and definition of new pathogenic mechanisms of insulin resistance and atherosclerosis.

The following classes of subjects at high risk will be considered:First degree relatives of patients with type 2 diabetes mellitus, patients with cardiovascular disease and stroke, patients with heart valve disease. age will be > 30 years, both gender.

详细描述

The primary outcome of the study is evaluation of glucose tolerance, insulin sensitivity and insulin secretion before and 2 hours post-glucose load Secondary outcomes are evaluation of endothelial function, of natriuretic peptides and free fatty acids, and inflammation before and 2 hours post-glucose load. New candidate genes will be also evaluated.

研究设计

研究类型
Observational
观察模型
Defined Population
时间视角
Other

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Fasting glucose levels <126 mg/dl
  • Age >30 years
  • Both male and female

排除标准

  • Type 1 diabetes
  • Known type 2 diabetes mellitus
  • Pregnancy
  • Impaired kidney and liver function
  • Previous history of malignancies

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验